Immunohistochemical staining showed that EDN/RB immunoreactivity was stronger in primary malignant melanomas than in dysplastic naevi, whereas metastatic melanomas were more strongly stained than primary malignant melanomas. This evidence concerns the gene RB1 and metastatic melanoma.